We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Vertex Pharmaceuticals Inc | NASDAQ:VRTX | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.92 | 0.23% | 401.08 | 371.34 | 408.70 | 405.665 | 397.59 | 401.50 | 1,063,962 | 05:00:08 |
From May 2021 to May 2024
By Matt Grossman
Vertex Pharmaceuticals Inc. has named Stuart A. Arbuckle its chief operating officer, the company said Wednesday.
Mr. Arbuckle previously served as the Boston-based pharmaceutical company's chief commercial officer. He has worked for Vertex since 2012.
Before joining Vertex, Mr. Arbuckle worked at Amgen Inc. and GlaxoSmithKline Plc.
Write to Matt Grossman at matt.grossman@wsj.com
(END) Dow Jones Newswires
August 04, 2021 08:53 ET (12:53 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Vertex Pharmaceuticals Chart |
1 Month Vertex Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
